| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8650931 | American Heart Journal | 2018 | 28 Pages |
Abstract
Bivalirudin±GPI was associated with significantly lower risk for major inhospital bleeding but no significant difference in 30-day or one year mortality, stent thrombosis or re-infarction compared with UFHâ¯Â±â¯GPI. The bleeding reduction associated with bivalirudin could be explained by the greater GPI use with UFH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dimitrios MD, PhD, Sofia Sederholm MD, PhD, Stefan MD, PhD, Sasha MD, PhD, David MD, PhD, Eva MD, PhD, Joakim MD, PhD,